Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN)
CAPS Rating:
A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.
RSS Headlines
Fool UK
Recs
As I see it, yes